Guilford regulatory update

U.S. Patent No. 5,626,862 issued to Massachusetts Institute of Technology (Cambridge, Mass.) and Johns Hopkins University (Baltimore, Md.) covering controlled local delivery of chemotherapeutic agents to treat solid tumors. GLFD has an exclusive license to the patent.

The patent covers the composition of matter and the use of various polymers in conjunction with chemotherapeutic agents, such as paclitaxel and the topoisomerase inhibitor camptothecin, and their use in the local delivery of such compounds to treat solid tumors. ...